Accord Drug Patent Portfolio
Accord owns 1 orange book drug protected by 4 US patents Given below is the list of Accord's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11717555 | Pharmaceutical compositions having a selected release duration | 01 Jan, 2039 | Active |
| US10646572 | Pharmaceutical compositions with enhanced stability | 16 Jan, 2027 | Active |
| US9572857 | Pharmaceutical compositions with enhanced stability | 16 Jan, 2027 | Active |
| US9744207 | Pharmaceutical compositions with enhanced stability | 16 Jan, 2027 | Active |
Latest Legal Activities on Accord's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Accord.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| transaction for FDA Determination of Regulatory Review Period | 29 Feb, 2024 | US9572857 |
| transaction for FDA Determination of Regulatory Review Period | 29 Feb, 2024 | US10646572 |
| transaction for FDA Determination of Regulatory Review Period | 29 Feb, 2024 | US9744207 |
| transaction for FDA Determination of Regulatory Review Period | 07 Feb, 2024 | US9744207 |
| transaction for FDA Determination of Regulatory Review Period | 07 Feb, 2024 | US9572857 |
| transaction for FDA Determination of Regulatory Review Period | 07 Feb, 2024 | US10646572 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 20 Oct, 2023 | US10646572 |
| Entity Status Set To Undiscounted (Initial Default Setting or Status Change) | 19 Oct, 2023 | US10646572 |
|
Email Notification
Critical
| 08 Aug, 2023 | US11717555 |
| Patent eGrant Notification | 08 Aug, 2023 | US11717555 |
|
Recordation of Patent Grant Mailed
Critical
| 08 Aug, 2023 | US11717555 |
| Mail Patent eGrant Notification | 08 Aug, 2023 | US11717555 |
|
Electronic Review
Critical
| 08 Aug, 2023 | US11717555 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 08 Aug, 2023 | US11717555 |
| Recordation of Patent eGrant | 08 Aug, 2023 | US11717555 |
Accord's Family Patents
Accord drugs have patent protection in a total of 15 countries. It's US patent count contributes only to 31.8% of its total global patent coverage. 1 country has all of their patents expired or invalidated which has opened up potential generic launch opportunities in this particular country. Click
below to unlock the full patent family tree.
Accord Drug List
Given below is the complete list of Accord's drugs and the patents protecting them.
1. Camcevi Kit
Camcevi Kit is protected by 4 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11717555 | Pharmaceutical compositions having a selected release duration |
01 Jan, 2039
(14 years from now)
| Active |
| US10646572 | Pharmaceutical compositions with enhanced stability |
16 Jan, 2027
(2 years from now)
| Active |
| US9572857 | Pharmaceutical compositions with enhanced stability |
16 Jan, 2027
(2 years from now)
| Active |
| US9744207 | Pharmaceutical compositions with enhanced stability |
16 Jan, 2027
(2 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Camcevi Kit's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List